Acquisition Accelerates Company’s Worldwide Expansion, Expands The DocuSign Global Trust Network

SAN FRANCISCO – March 11, 2015 – Today, DocuSign, Inc. (DocuSign®) announced its acquisition of Algorithmic Research, Ltd. (ARX). The acquisition builds on a three year business partnership between DocuSign and ARX, bringing together ARX’s best-in-class CoSign digital signature technology with the world’s leading Digital Transaction Management (DTM) platform, to empower customers to transact business with full trust and confidence anywhere in the world. DocuSign’s acquisition of ARX further accelerates the company’s worldwide expansion and broadens The DocuSign Global Trust Network.

“DocuSign is the undisputed global standard for Digital Transaction Management,” said Gadi Aharoni, CEO, ARX. “ARX customers will benefit from the robust cloud-based workflow and transaction management capabilities of the DocuSign Digital Transaction Management (DTM) platform – complete with Bank Grade Security and Carrier Grade Availability – to empower them to transact anytime, anywhere, on any device. Securely.”

“ARX has been a great partner for DocuSign for many years,” said Keith Krach, DocuSign Chairman and CEO. “They have a high performance team, strong customer focus, world class technology, and deep domain expertise. We’re delighted to have ARX’s customers and partners join The DocuSign Global Trust Network.”

ARX, with its CoSign line of products, offers important compliance certifications critical for customers in Europe, the Americas and Asia, including NIST’s FIPS 140-2 Level 3 and Common Criteria EAL4+ certifications. CoSign is used by millions of users globally to transact business in the most highly regulated industries, including life sciences, government and public sector, financial services, healthcare and engineering. The CoSign product line includes native integrations into a wide variety of systems including Microsoft Office, Office 365, SharePoint, Nintex, K2, OpenText, Oracle, Alfresco and more.

ARX has more than 2,000 customers, including AES; AFREN; AstraZeneca; Bayer; Bechtel; Big Rivers Electric Corporation; Black & Veatch; Braun Intertec; Burns & McDonnell; Capita Asset Services; City of Amsterdam; Clallam County PUD; Commodity Futures Trading Commission; County of Contra Costa, California; County of Hawaii, Hawaii; County of Johnson, Kansas; Curtiss-Wright Corporation; the Department of Justice and Constitutional Development, Republic of South Africa; EDP&L; Encana; Energy Solutions; Eni; European Court of Human Rights; the Federal Bureau of Investigation; the Farm Credit Association; First Energy; Forum Energy Technologies; Foster Wheeler; Gas Natural; GlaxoSmithKline (GSK); Glencore Xstrata; Grant County PUD; Harvard Clinical Research Institute; Hawai’i Gas; Hellenic Parliament; Homestake DUSEL; International Criminal Court; International Partnership for Microbicides; Intesa San Paolo Bank; Italian Ministry of Education; Italian Ministry of Justice; Johnson & Johnson; Kane County Circuit Court; Luminant Energy; McKesson; MEG Energy; Modec; Muscular Dystrophy Association; National Aeronautics and Space Administration (NASA); National Cancer Center Japan; the National Nuclear Security Administration; Nigerian National Petroleum Corporation (NNPC); Novartis; Novozymes; Oakridge National Laboratory; Oglethorpe Power; PetroChina; PetroJam; Pharmaceutical Product Development (PPD); Roche; Salt River Project; Sanofi; Seitel; Senate of Italy; State of Minnesota Judicial Branch; State of South Carolina Administrative Law Court; State of South Carolina Department of Transportation; Terracon; Total; UniCredit Bank; United States Courts; the U.S. Department of Health and Human Services; the U.S. Department of Homeland Security; the U.S. Department of Energy; the U.S. Department of Justice; the U.S. Department of Veterans Affairs; the U.S. Parole Commission; the U.S. Probation Office; the Virginia Supreme Court; Yarra Valley Water; Zimmer; and many others.

The terms of the deal were not disclosed. Individuals interested in learning more may visit or


Media Contacts:
Kristin Treat                                                                                     
DocuSign, Inc.                                                                                 
+1 (215) 317-9091                                                                                                                                                                           

About ARX
ARX is a leading global provider of digital signature solutions. Millions of people at large enterprises, SMBs, governments and cloud services around the world use the company’s flagship CoSign products on a daily basis to easily add secure digital signatures to documents in Word, Excel, PDF, SharePoint, OpenText, Oracle, Alfresco, Nintex, K2, and many other applications and file formats. By seamlessly integrating digital signatures into existing document-related workflows, applications and services across their organizations, CoSign customers quickly transform their slow and expensive signature-dependent processes into quick and efficient paper-free ones. They rapidly reach ROI through significant reductions in process times and paper-related costs, while ensuring trust, integrity, control and compliance across their business and IT environments.

About DocuSign, Inc.
DocuSign® is The Global Standard for Digital Transaction Management®. DocuSign helps more than 100,000 companies across nearly every industry and department make their digital transformation by putting an end to the paper chase. More than 50 million people in 188 countries turn to DocuSign to manage their most important transactions—digitally. DocuSign's DTM platform supports legally compliant signature processes tailored to meet requirements globally with localization in 43 languages. Every day more than 50,000 new users join The DocuSign Global Trust Network to increase speed to results, reduce costs, enhance security and compliance, and delight clients with a secure digital experience. For more information, visit or call 877.720.2040.

Copyright 2003-2015. DocuSign, Inc. is the owner of DOCUSIGN® and all of its other marks, All other marks appearing herein are the property of their respective owners.